Cargando…
Comparison of intranasal and nebulized dexmedetomidine for premedication in pediatric patients: A non-inferiority randomized controlled trial
BACKGROUND AND AIMS: Dexmedetomidine is a highly selective α-2 adrenoreceptor agonist and has been found to be an effective premedication agent when administered via the intranasal route. We aimed to compare the efficacy of dexmedetomidine premedication administered via intranasal route and through...
Autores principales: | Verma, Shilpi, Bhatia, Pradeep Kumar, Sharma, Vandana, Mohammed, Sadik, Saran, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912882/ https://www.ncbi.nlm.nih.gov/pubmed/36778820 http://dx.doi.org/10.4103/joacp.JOACP_6_21 |
Ejemplares similares
-
Comparison of intranasal dexmedetomidine-midazolam, dexmedetomidine-ketamine, and midazolam-ketamine for premedication in paediatric patients: a double-blinded randomized trial
por: Vaishnavi, BD, et al.
Publicado: (2023) -
Intranasal Fentanyl, Midazolam and Dexmedetomidine as Premedication in Pediatric Patients
por: Chatrath, Veena, et al.
Publicado: (2018) -
Comparison of intranasal dexmedetomidine and dexmedetomidine-ketamine for premedication in pediatrics patients: A randomized double-blind study
por: Bhat, Ravi, et al.
Publicado: (2016) -
Comparison of nebulized dexmedetomidine and ketamine for premedication in pediatric patients undergoing hernia repair surgery: a randomized comparative trial
por: Singariya, Geeta, et al.
Publicado: (2022) -
A comparison of intranasal ketamine and intranasal midazolam for pediatric premedication
por: Narendra, P. L., et al.
Publicado: (2015)